STUCCI, LUIGIA STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 3.657
AS - Asia 1.439
EU - Europa 1.151
SA - Sud America 355
AF - Africa 80
OC - Oceania 3
Totale 6.685
Nazione #
US - Stati Uniti d'America 3.597
SG - Singapore 570
CN - Cina 322
BR - Brasile 276
IT - Italia 214
SE - Svezia 194
RU - Federazione Russa 184
HK - Hong Kong 151
VN - Vietnam 133
DE - Germania 108
GB - Regno Unito 106
FR - Francia 95
FI - Finlandia 72
IN - India 50
BD - Bangladesh 39
CA - Canada 36
UA - Ucraina 31
ID - Indonesia 30
CI - Costa d'Avorio 29
NL - Olanda 28
AR - Argentina 27
BE - Belgio 23
TR - Turchia 20
ZA - Sudafrica 18
IQ - Iraq 17
ES - Italia 16
SA - Arabia Saudita 15
CO - Colombia 14
IE - Irlanda 14
PL - Polonia 14
MX - Messico 13
NP - Nepal 13
JP - Giappone 12
AT - Austria 11
CL - Cile 11
LT - Lituania 9
MY - Malesia 8
PH - Filippine 8
PK - Pakistan 8
PY - Paraguay 8
AL - Albania 7
EC - Ecuador 7
UZ - Uzbekistan 7
JO - Giordania 6
KE - Kenya 6
MA - Marocco 6
TN - Tunisia 6
KR - Corea 5
VE - Venezuela 5
GR - Grecia 4
IR - Iran 4
TH - Thailandia 4
AU - Australia 3
BO - Bolivia 3
HU - Ungheria 3
IL - Israele 3
PE - Perù 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BH - Bahrain 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
JM - Giamaica 2
KW - Kuwait 2
PT - Portogallo 2
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MQ - Martinica 1
MR - Mauritania 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RE - Reunion 1
RS - Serbia 1
SI - Slovenia 1
SO - Somalia 1
Totale 6.682
Città #
Ashburn 445
Fairfield 373
Singapore 329
Woodbridge 318
Chandler 301
Houston 182
San Jose 166
Seattle 162
Nyköping 159
Cambridge 149
Hong Kong 144
Beijing 129
Wilmington 126
Ann Arbor 116
Jacksonville 73
New York 70
Los Angeles 67
Lauterbourg 53
Lawrence 49
Dallas 47
Helsinki 47
Roxbury 47
Nanjing 46
Bari 42
Ho Chi Minh City 38
Munich 35
Des Moines 33
Abidjan 29
Brooklyn 27
Inglewood 27
Santa Clara 24
São Paulo 24
Brussels 22
Princeton 22
Hanoi 21
London 21
Paris 19
Council Bluffs 18
San Diego 18
Jakarta 17
Chicago 16
Dong Ket 16
Nuremberg 15
Denver 14
Dublin 14
North Bergen 14
Poplar 14
Buffalo 13
Montreal 13
Redwood City 13
Boardman 12
Chennai 11
Curitiba 11
Tokyo 11
Amsterdam 10
Frankfurt am Main 10
Milan 10
Rome 10
Stockholm 10
Warsaw 10
Washington 10
Dearborn 9
Kathmandu 9
Moscow 9
Nanchang 9
Orem 9
Belo Horizonte 8
Columbus 8
Düsseldorf 8
Hebei 8
Johannesburg 8
Ottawa 8
Phoenix 8
Porto Alegre 8
Santiago 8
The Dalles 8
Toronto 8
Atlanta 7
Dhaka 7
Manchester 7
New Delhi 7
Tashkent 7
Tianjin 7
Amman 6
Baghdad 6
Da Nang 6
Hải Dương 6
Rio de Janeiro 6
San Mateo 6
Shenyang 6
Vienna 6
Augusta 5
Bogotá 5
Haiphong 5
Marseille 5
Mexico City 5
Nairobi 5
Salt Lake City 5
Asunción 4
Bologna 4
Totale 4.558
Nome #
Animal-type melanoma: Dog or wolf? A review of the literature and a case report 205
Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells. 185
Adenocarcinoma of the ceruminous glands: role of the VMAT 184
Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity 177
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. 176
Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma 172
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. 170
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 170
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 167
Immune system and melanoma biology: A balance between immunosurveillance and immune escape 166
Avβ3 integrin: Pathogenetic role in osteotropic tumors 166
Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition 164
Double heterozygosity for BRCA1 pathogenic variant and BRCA2 polymorphic stop codon K3326X: A case report in a southern Italian family 161
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. 161
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications. 159
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 150
null 149
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 148
PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. 144
Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma 138
Reframing Breast Cancer Experience through Metaphors: A New Operative System to Enhance Patients’ Healing Process 137
An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation. 136
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 135
Does cilengitide deserve another chance? 134
Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus 130
The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice 129
Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management 128
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival 125
Current status and perspectives in immunotherapy for metastatic melanoma 124
COVID 19: HEALTH, STATISTICAL AND CONSTITUTIONAL ASPECTS 123
Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma 113
miRNAs in melanoma: a defined role in tumor progression and metastasis 109
The immune escape in melanoma: role of the impaired dendritic cell function 106
Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation 105
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study 105
[Novel markers in osteo-oncology: the tartrate resistant acid phosphatase in myeloma bone disease]. FT Alla ricerca di nuovi marcatori in osteo-oncologia: la fosfatasi acida tartrato-resistente nella malattia ossea mielomatosa 104
Dendritic Cells and Malignant Plasma Cells: An Alliance in Multiple Myeloma Tumor Progression? 103
Effect of vitaxin on hyperactive osteoclastogenesis in multiple myeloma: a preclinical study 103
A large metastatic intramammary lesion of an occult melanoma 97
Dietary compounds and cutaneous malignant melanoma: Recent advances from a biological perspective 94
Characterization of the metastatic behavior and gene expression profile (RNAseq) of different melanoma cell lines: a comprehensive in vivo model. 93
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 90
Circulating dendritic cell levels identify high-risk stage II-III melanoma patients: A potential role as additional prognostic marker 89
Non-Melanoma Skin Cancers: Biological and Clinical Features 86
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group 79
null 78
Effect of age on melanoma risk, prognosis and treatment response 74
Circulating dendritic cell levels identify high-risk stage II-III melanoma patients: a potential role as additional prognostic marker. 74
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice 73
Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma. 67
Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgery 66
null 66
null 62
null 57
Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence? 54
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors 51
Te avbeta3/avbeta5 blockage by Cilengitide disables the osteoclast-like differentiation of malignant plasma cells in multiple myeloma 40
Does clilengitide deserve another chance? 36
null 33
Totale 6.920
Categoria #
all - tutte 28.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.284


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021184 0 0 0 0 0 0 0 0 0 72 60 52
2021/2022374 18 21 5 17 15 38 9 20 32 37 63 99
2022/2023727 106 98 46 70 69 100 14 85 107 7 15 10
2023/2024310 16 49 18 51 30 66 11 20 8 4 3 34
2024/20251.130 37 14 98 60 40 91 130 112 75 64 137 272
2025/20262.204 383 112 156 260 344 130 234 93 282 210 0 0
Totale 6.920